Dr. Philip Greenberg elected a Distinguished Fellow of the American Association of Immunologists

He is among 52 immunologists selected for the AAI 2019 inaugural class of fellows, including 5 Nobel laureates
Dr. Phil Greenberg
Dr. Phil Greenberg Fred Hutch file photo

The American Association of Immunologists has selected Fred Hutchinson Cancer Research Center’s Dr. Philip Greenberg, a world expert in cancer immunotherapy, as an AAI 2019 Distinguished Fellow. He is among 52 researchers selected for the inaugural class of fellows.

Immunotherapy, an offshoot of Fred Hutch’s pioneering work in bone marrow transplantation, harnesses the body’s immune system to eliminate cancer cells.

Greenberg, head of the Program in Immunology at Fred Hutch, is also a professor of medicine and immunology at the University of Washington School of Medicine and a member of the Parker Institute for Cancer Immunotherapy. He specializes in a form of immunotherapy called T-cell therapy. His early discoveries about how to target diseases with these immune cells have been foundational for this field.

In the lab and the clinic, Greenberg’s team continues to develop new strategies for genetically reprogramming a patient’s T cells to recognize and kill cancers. They are creating new T-cell therapies for patients with acute myeloid leukemia, ovarian cancer, pancreatic cancer, and other malignancies.

A graphic that reads "Good News at Fred Hutch" and "Read more"

The inaugural class of Distinguished Fellows includes five Nobel laureates (Drs. James Allison of MD Anderson Cancer Center, David Baltimore of the California Institute of Technology, Tasuku Honjo of Kyoto University, Susumu Tonegawa of the Massachusetts Institute of Technology and Rolf Zinkernagel of the University of Zurich).

According to AAI President Dr. JoAnne Flynn, election as a Distinguished Fellow is among the highest honors bestowed by the organization.

The fellows, many of whom Greenberg considers to be longtime friends and colleagues, will be recognized at the AAI annual meeting, Immunology 2019, to be held May 9-13 in San Diego.

Read more about Fred Hutch achievements and accolades.

Kristen Woodward, a former associate editor at Fred Hutchinson Cancer Center, had been in communications at Fred Hutch for more than 20 years. Before that, she was a managing editor at the University of Michigan Health System and a reporter/editor at The Holland Sentinel, a daily in western Michigan. She has received many national awards for health and science writing. She received her B.A. in journalism from Michigan State University. 

Related News

All news
Drs. Fred Appelbaum and Phil Greenberg elected to AACR Academy They are among 22 scientists from around the world to join the 2019 class of Fellows March 25, 2019
Dr. Phil Greenberg named 2018 Leader in Health Care Seattle Business Magazine honors cancer immunotherapy pioneer for his work on T-cell therapy March 2, 2018
Teaming up to understand mysterious microproteins Dr. Arvind Subramaniam with multi-institutional team receives NIH Transformative Research Award to explore forces shaping microprotein evolution, potential roles in immunity and autoimmunity November 28, 2023

Help Us Eliminate Cancer

Every dollar counts. Please support lifesaving research today.